Persistence of the effects of Cerebrolysin (FPF 1070) on cognition and qEEG slowing in vascular dementia patients: Results of a 3-month extension study.
Phase of Trial: Phase III
Latest Information Update: 14 Mar 2011
At a glance
- Drugs Brain extract (Primary)
- Indications Vascular dementia
- Focus Therapeutic Use
- 14 Mar 2011 New trial record